期刊文献+

胶质瘤明胶酶A基因表达研究 被引量:2

Gene Expression of Gelatinase A in Gliomas
下载PDF
导出
摘要 目的 了解明胶酶A在胶质细胞瘤发展中的作用。方法 取36例脑胶质细胞瘤患者的肿瘤组织及正常脑组织,其中Ⅰ~Ⅱ胶质瘤13例,Ⅲ~Ⅳ级胶质瘤23例。提取组织总RNA;用逆转录共扩增定量PCR方法测定明胶酶A(MMP2)基因表达水平。结果 Ⅲ~Ⅳ级胶质瘤明胶酶A基因表达水平(1.41±0.43)明显高于Ⅰ~Ⅱ级胶质瘤(0.54±0.07)及正常脑组织(0.29±0.04)。胶质瘤MMP2基因表达水平与肿瘤大小无关,而与肿瘤分化程度有关。结论 明胶酶A在脑胶质瘤的进展中可能起重要作用。 Objective To investigate the role of gelatinase A in the progression of human gliomas. Methods Twenty-three patients with grade Ⅲ -Ⅳ of gliomas and 13 patients with grade Ⅰ - Ⅱ of gliomas were selected for the evaluation of gelatinase A (MMP2) gene expression levels, and the normal brain tissues obtained during the operation served as control. The total RNA in the gliomas and the normal brain tissues was isolated and MMP2 gene expression levels were measured by the techniques of reverse transcription polymerase chain reaction. Results MMP2 gene expression level in grade Ⅲ-Ⅳ glioma tissues (1.41±0.43) was significantly higher (P<0.01) than those in grade Ⅰ-Ⅱ glioma(0.54±0.07) and the normal brain tissues (0.29±0.04). MMP2 gene expression levels had strong correlation with the degree of histological differentiation of the tumor but not with the tumor size. Conclusion Gelatinase A may play an important role in the progression of gliomas.
出处 《中国临床神经外科杂志》 2002年第2期101-102,共2页 Chinese Journal of Clinical Neurosurgery
关键词 胶质瘤 明胶酶A 基因表达 Glioma Gelatinase :A Gene expression
  • 相关文献

参考文献8

  • 1[1]Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis [J]. Eur Respir J, 1994, 7:2062~2072.
  • 2[2]Noonan KE, Beck C, Holzmayer TA, et al . Quantitative analysis of MDRl(multidrug resistance) gene expression in human tumors by polymerase chain reaction [J].Proc Natl Acad Sci USA, 1990, 87: 7160~7164.
  • 3[3]Lichtinghaen R, Helmbrecht T, Arndt B, et al . Expression Pattern of matrix metalloproteinases in Human Liver [J]. Eur J Clin Chem Biochem, 1995, 33: 65~71.
  • 4[4]Upadhgay J, Shekarriz B, Nemeth JA, et al . Membrane type l-matrix metalloproteinase (MTI-MMP) and MMP0immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia [J]. Clin Cancer Res. 1999,(12): 4105~4110.
  • 5[5]Garbett EA, Reed MW, Brown NJ, et al . Proteolysis in human breast and colorectal cancer [J]. Br J Cancer,1999, 81(2): 287~293.
  • 6[6]Ellenrieder V, Alber B, Lacher U, et al . Role of MTMMPs and MMP-2 in pancreatic cancer progression [J].Iht J Cancer, 2000, 85 (1): 14~20.
  • 7[7]Chintala SK, Sawaya R, Gokaslan ZL, et al . Modulation of matrix metalloproteinase-0 and invasion in human glioma by alpha 3 beta i integrin [J]. Cancer Lett,1996, 103:201~208
  • 8[8]Nakagawa T, Kubota T, Kubota M, et al . Secretion ofmatrix metalloproteinase -2 (72D gelatinase/type 1V collagenase=gelatinase A) by malignant human gliomacell line: implications for the growth and cellular invasion of the extracellular marix [J]. J Neurooncol,1996, 28: 13~24.

同被引文献19

  • 1马春晓,徐国本,宋来君,孙剑瑞,李红伟.脑膜瘤MMP-9表达及其对血管形成、脑浸润和瘤周水肿的影响[J].中国临床神经外科杂志,2004,9(4):262-264. 被引量:3
  • 2Salaita k, Groves JT. Roles of the cytoskeleton in regulating EphA2 signals [J]. Commun Integr Biol, 2010, 3(5): 454-457.
  • 3Cheng N, Brantley DM, Liu H, et al. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis [J]. Mol Cancer Res, 2002, 1 ( 1 ):2-11.
  • 4Kunishio K, Okada M, Matsumoto Y, et al. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors [J]. Brain Tumor Pathol, 2003, 20(2):39-45.
  • 5Nakada M, Kita D, Futami K, et al. Roles of membrane type-1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of hu- man malignant glioma[J].J Neurosurg,2001,94(3):464-473.
  • 6Sulman EP, Tang XX, Allen C, et al. ECK, a human EPH-related gene, maps to lp36.1, a common region of aheration in human cancers [J]. Genomics, 1997, 40 (2): 371-374.
  • 7Kataoka H, Igarashi H, Kanamori M, et al. Correlation of EphA2 overexpression with high microvessel count in human primary colorectal cancer[J]. Cancer Sci, 2004, 95(2): 136-141.
  • 8Holm R, de Putte GV, Suo Z, et al. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis [J]. Int J Med Sci, 2008, 5 (3):121-126.
  • 9Lu C, Shahzad MM, Wang H, et al. EphA2 overexpression promotes ovarian cancer growth [J]. Cancer Biol Ther, 2008, 7(7):1098-1103.
  • 10Abraham S, Knapp DW, Cheng L, et ah Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder[J]. Clin Cancer Res, 2006, 12(2):353-360.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部